Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

Research investigates the effectiveness of oral antiviral medications, Molnupiravir and Nirmatrelvir-Ritonavir, in treating patients with type 2 diabetes and mild to moderate COVID-19. The study aims to determine the efficacy of these medications in reducing adverse outcomes in this specific population.

24 May 2023

Heart transplants from COVID-19 donors: Mixed outcomes revealed in early analysis

In a recent study published in the Journal of the American College of Cardiology, researchers investigated coronavirus disease 2019 (COVID-19)-infected donor use, donor and recipient characteristics, and early post-heart transplantation (HT) outcomes in the United States (US).

23 May 2023

Vaccination coverage drops in U.S. schools, raising concerns of outbreaks

Research highlights the decline in national coverage of state-required vaccines among kindergarten students during the 2020-2021 and 2021-2022 school years. Despite a low exemption rate, vaccination coverage decreased further in the latter year, indicating ongoing COVID-19 disruptions and emphasizing the need for increased follow-up with under-vaccinated students to protect against vaccine-preventable diseases.

22 May 2023

Genetic insights unveil promising therapeutic targets for critical COVID-19

Critical COVID-19 illness reveals genetic associations with immunomodulatory therapies, as identified in a comprehensive analysis of 24,202 cases. This study uncovers novel genome-wide significant associations, highlighting potential druggable targets for inflammatory signaling, immunometabolism, and viral replication, offering insights into therapeutic implications.

21 May 2023

Breast milk shields newborns: COVID-19 antibodies and microbiota from vaccinated mothers provide dual defense

Research paper discusses the differences in microbiota between high and low IgA subjects after the second dose of the COVID-19 vaccine. The study found that certain microbial features in breast milk can predict levels of anti-SARS-CoV-2 antibodies in breast milk one week post-second dose.

21 May 2023

Synthetic delivery vector STxB induces mucosal immunity against viral antigens

Research describes the development of a synthetic delivery vector called STxB for mucosal vaccination. It induces mucosal immunity, including resident memory CD8+ T cells and IgA antibodies, against antigens derived from mucosal viruses when administered intranasally in mice.

21 May 2023

Anthropause: the influence of the SARS-CoV-2 outbreak on behavioral patterns of sika deer in Japan

Researchers investigated the impact of the anthropause, or stagnation, in human activity due to a decrease in tourist visits to Nara Park, central Japan, caused by the COVID-19 pandemic, which reduced the population and altered the behavior of Sika deer inhabitants.

19 May 2023

A novel role for macrophage-activation signaling in orchestrating the recruitment process in response to the SARS-CoV-2 spike protein

Researchers derived peptides from the SARS-CoV-2 spike protein to assess COVID-19-associated inflammatory changes using zebrafish models.

19 May 2023

Both vaccine strain and adjuvant selection are critical elements for improving the breadth of protective immunity against enterovirus D68

Researchers demonstrated the production of cross-clade neutralizing antibodies in response to EV-D68.

19 May 2023

Wastewater surveillance reveals hidden scale of mpox rpidemic, challenging official figures

Research highlights the potential of wastewater-based epidemiology as a complementary tool to clinical monitoring for assessing the magnitude of a mpox epidemic. Findings suggest that the presence of mpox DNA in wastewater does not directly correspond to the number of hospitalizations, indicating the underestimation of the epidemic's scale and unidentified cases.

19 May 2023

COVID's latest twist: New XBB variant gains strength through recombination, outsmarting immunity and amplifying fusogenicity

Research discusses the emergence of a highly diversified SARS-CoV-2 Omicron subvariant called XBB, which is spreading rapidly around the world. XBB emerged through the recombination of two cocirculating BA.2 lineages, BJ.1 and BM.1.1.1, during the summer of 2022.

18 May 2023

Investigating the changes in severity and epidemiology of respiratory syncytial virus infections among children

Shifting Epidemiology and Severity of Respiratory Syncytial Virus in Children During the COVID-19 Pandemic.

18 May 2023

Researchers find that SARS-CoV-2 directly infects hepatocytes that cause hyperglycemia

Researchers investigate whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused hyperglycemia.

18 May 2023

Post-COVID condition varies by variant and vaccination status

Research investigates the post-COVID-19 condition, analyzing its profiles based on viral variants and vaccination status. Understanding these profiles can aid in personalized patient care.

17 May 2023

Identifying trajectories of the evolution of post-COVID-19 condition

Researchers analyzed the evolution of the post-coronavirus disease 2019 condition.

17 May 2023

Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses

Researchers generated six human monoclonal antibodies that prevented infection.

17 May 2023

Updated evidence suggests that masks may be associated with a reduction in risk for SARS-CoV-2 infection

Researchers presented updated evidence of the effectiveness of masks in preventing SARS-CoV-2.

17 May 2023

Are masks effective in the protection against COVID-19?

Researchers discussed the efficacy of masks in preventing coronavirus disease 2019 (COVID-19).

17 May 2023

Long-COVID's crippling aftermath: Study reveals persistent symptoms severely impact quality of life, especially in women

Research examines the impact of long-Covid syndrome on the health-related quality of life (HRQoL) of patients with mild or moderate SARS-CoV-2 infections. It reveals significant impairments in physical and mental health, emphasizing the need for long-term surveillance and support for affected individuals.

16 May 2023

Novel 'CLEVER' method accelerates engineering and genetic study of SARS-CoV-2 and its variants

Researchers described rapid mutagenesis and rescue of SARS-CoV-2 variants without cloning.

16 May 2023

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

Heart transplants from COVID-19 donors: Mixed outcomes revealed in early analysis

Vaccination coverage drops in U.S. schools, raising concerns of outbreaks

Genetic insights unveil promising therapeutic targets for critical COVID-19

Breast milk shields newborns: COVID-19 antibodies and microbiota from vaccinated mothers provide dual defense

Synthetic delivery vector STxB induces mucosal immunity against viral antigens

Anthropause: the influence of the SARS-CoV-2 outbreak on behavioral patterns of sika deer in Japan

A novel role for macrophage-activation signaling in orchestrating the recruitment process in response to the SARS-CoV-2 spike protein

Both vaccine strain and adjuvant selection are critical elements for improving the breadth of protective immunity against enterovirus D68

Wastewater surveillance reveals hidden scale of mpox rpidemic, challenging official figures

COVID's latest twist: New XBB variant gains strength through recombination, outsmarting immunity and amplifying fusogenicity

Investigating the changes in severity and epidemiology of respiratory syncytial virus infections among children

Researchers find that SARS-CoV-2 directly infects hepatocytes that cause hyperglycemia

Post-COVID condition varies by variant and vaccination status

Identifying trajectories of the evolution of post-COVID-19 condition

Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses

Updated evidence suggests that masks may be associated with a reduction in risk for SARS-CoV-2 infection

Are masks effective in the protection against COVID-19?

Long-COVID's crippling aftermath: Study reveals persistent symptoms severely impact quality of life, especially in women

Novel 'CLEVER' method accelerates engineering and genetic study of SARS-CoV-2 and its variants

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Newsletters you may be interested in